SAFETY, TOLERABILITY, AND PHARMACOKINETICS ATER SINGLE AND MULTIPLE DOSES OF MK-5172, A NOVEL HCV NS3/4A PROTEASE INHIBITOR WITH POTENT ACTIVITY AGAINST KNOWN RESISTANCE MUTANTS, IN HEALTHY SUBJECTS
HEPATOLOGY（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要